- What will investors be looking out for this reporting period?
- The evolution of social media in crisis communications - Part Two: When the crisis hits
- The evolution of social media in crisis communications – Part One: Pre-crisis planning
- ASEAN Dengue Day: Island Pharmaceuticals Investor briefing video
- Are you ready for the 2022 Financial Year? What you need to know and trends to watch out for.
Sleep apnoea is a potentially serious condition but only one in five patients are in care.
Oventus (ASX:OVN) is innovating sleep apnoea care with its patented airway design that creates a 'second nose'. Using CAD software to create a 3D drawing of the patient’s mouth and bite, Oventus uses 3D printing technology to manufacture these custom-made medical-grade mouthguards from titanium.
In this interview with Health Invest TV , Oventus Clinical Director Dr Chris Hart speaks to IR Department Managing Director Jane Lowe about the unmet patient need in the sleep apnoea market and why Oventus' platform is one of the most exciting treatment innovations in decades.
About IR Department
Established in 2007, Investor Relations Department Pty Ltd (IR Department) is an independent corporate and financial communications agency, known for delivering outstanding results for clients.
Our experienced consultants understand the importance of matching business objectives with communications campaigns. We translate complex data and messaging into understandable investor communications that form the backbone of successful investor engagement strategies, and support appropriate valuations.
We provide expert consulting services across the areas of investor relations, public relations, marketing and communications. We like to do what we say we’re going to do – delivering to brief and reporting to clients as we go, so our clients aren’t left guessing about what we’re doing, and they can measure our collective success along the way.
For more information or to contact us, please visit www.irdepartment.com.au.